21 results
8-K
EX-99.1
ESPR
Esperion Therapeutics Inc.
9 May 23
Esperion Reports First Quarter 2023 Financial Results
7:22am
rapid adoption in demand for this practice-changing treatment from prescribers and pharmacists. International Lipid Expert Panel guidelines now … to lead to wide acceptance by providers, patients, and payers.
The International Lipid Expert Panel (ILEP) recommended use of bempedoic acid ahead
8-K
EX-99.1
ESPR
Esperion Therapeutics Inc.
4 May 23
Other Events
9:26am
in the treatment of statin intolerant patients. After the publication of the CLEAR Outcomes Study results, the International Lipid Expert Panel (ILEP) published … of the CLEAR Outcomes Study, the
International Lipid Expert Panel (ILEP) published positive “recommendations for
the use of bempedoic acid
8-K
EX-99.1
98ap zs8us
1 Nov 22
Esperion Reports Third Quarter 2022 Financial Results and Provides Company Update
7:23am
PRE 14A
o26fdjk0j9bxxdy
4 Apr 22
Preliminary proxy
4:03pm
8-K
0iaz2p4u
28 Jun 21
ESPERION Appoints JoAnne Micale Foody, MD, FACC, FAHA as Chief Medical Officer
4:03pm
8-K
EX-99.1
v1ajnkw8 96g
28 Jun 21
ESPERION Appoints JoAnne Micale Foody, MD, FACC, FAHA as Chief Medical Officer
4:03pm
424B5
a7zc qpqq3sioxs2vco
16 Oct 14
Prospectus supplement for primary offering
12:00am
424B5
h65ve518p32qqh
14 Oct 14
Prospectus supplement for primary offering
12:00am
424B4
coe 26yhi
26 Jun 13
Prospectus supplement with pricing info
12:00am
S-1/A
yumnglrv6t0r
7 Jun 13
IPO registration (amended)
12:00am
S-1/A
EX-3.4
5vrmsw4rtst57orun
7 Jun 13
IPO registration (amended)
12:00am